UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024140
Receipt number R000027796
Scientific Title effect of change in heart rate on valvular disease and ventricular function
Date of disclosure of the study information 2016/11/01
Last modified on 2016/09/23 16:42:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

effect of change in heart rate on valvular disease and ventricular function

Acronym

effect of change in heart rate on valvular disease and ventricular function

Scientific Title

effect of change in heart rate on valvular disease and ventricular function

Scientific Title:Acronym

effect of change in heart rate on valvular disease and ventricular function

Region

Japan


Condition

Condition

valvuler disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to study the effect of change in heart rate on valvuler heart disease and ventricular function.

Basic objectives2

Others

Basic objectives -Others

to assess the optimum heart rate of valvular disease

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

severity of valvular disease
ventricular function

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

We change heart rate of pacemaker every 10 bpm from 50 to 100bpm. We examine a transthoracic echocardiography to assess the effect of change in heart rate on severity of valvular disease and ventricular function. We return heart rate to standard setting after testing

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

patients with terminal pacemaker whose maker is St.Jude Medical or Medtronic

Key exclusion criteria

acute coronary syndrome
severe aortic valve disease

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tohru Masuyama

Organization

Hyogo college of Medicine

Division name

Cardiovascular Division, Department of Internal Medicine

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan

TEL

0798-45-6553

Email

masuyama@hyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Miho Fukui

Organization

Hyogo college of Medicine

Division name

Cardiovascular Division, Department of Internal Medicine

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya 663-8501, Japan

TEL

0798-45-6553

Homepage URL


Email

m-fukui@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo college of Medicine

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 10 Month 15 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 09 Month 23 Day

Last modified on

2016 Year 09 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027796